Prenetics Global Limited Class A Ordinary Share (PRE) Stock Price, Quote & News

Company Profile

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into h...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 852 2210 9588

Website: www.prenetics.com

Address:

Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong

focafoca99 May. 4 at 1:50 PM

$PRE outlined its complete Bitcoin treasury divestment, selling about 510 BTC.

0 · Reply

SuperGreenToday May. 1 at 12:25 AM

$PRE Share Price: $16.62 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $2.12 – $2.62 Target Zone: $3.77 – $4.60 Potential Upside: 67% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksSCR Apr. 17 at 10:30 PM

$PRE initiated at $30 price target. IM8 brand hit $120M ARR in 12 months. Company debt-free with $170M cash. Athlete partnerships structured as equity, not endorsement fees. https://youtu.be/IIfurXL7wtc

1 · Reply

ZacksSCR Apr. 8 at 3:27 PM

Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz

0 · Reply

focafoca99 Apr. 2 at 7:57 PM

$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.

0 · Reply

Sidoti Mar. 30 at 12:21 PM

New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap

0 · Reply

Sidoti Mar. 20 at 4:55 PM

Prenetics Global Limited ($PRE) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_1d-20z12RkKM5y8lzKf6Xw

0 · Reply

positiveguy Mar. 19 at 5:17 PM

$PRE PLEASE BUY IGNITON FROM GAIA . THEY HAVE NO CLUE.

0 · Reply

DARKP00L Mar. 16 at 2:46 PM

$PRE 10:17 on Mar. 16 2026 Lake Street Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $29 #tradeideas

0 · Reply

STACKD0E Mar. 16 at 1:41 PM

$PRE 🙃✨

0 · Reply

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

May 7, 2026, 8:30 AM EDT - 6 days ago

Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

2026-03-31T13:31:53.000Z - 6 weeks ago

Prenetics files to sell 2.36M Class A ordinary shares for holders

2026-03-24T15:10:13.000Z - 7 weeks ago

Prenetics’ IM8 enters partnership with Superpower

Mar 24, 2026, 11:00 AM EDT - 7 weeks ago

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Mar 23, 2026, 3:00 PM EDT - 7 weeks ago

Prenetics Global Transcript: The 38th Annual Roth Conference

Mar 23, 2026, 11:30 AM EDT - 7 weeks ago

Prenetics Global Transcript: The 38th Annual Roth Conference

Mar 19, 2026, 9:15 AM EDT - 7 weeks ago

Prenetics Global Transcript: Sidoti March Small-Cap Virtual Conference

2026-03-16T12:46:14.000Z - 2 months ago

Prenetics initiated with a Buy at Lake Street

2026-03-06T13:12:18.000Z - 2 months ago

Prenetics authorizes $40M share repurchase program

2026-03-03T13:22:08.000Z - 2 months ago

Prenetics announces executive open market share purchases

2026-02-23T14:15:10.000Z - 2 months ago

Prenetics announces launch of Daily Ultimate Essentials PRO

Feb 18, 2026, 10:00 AM EST - 2 months ago

Prenetics Global Earnings Call Transcript: Q4 2025

2026-02-18T14:30:25.000Z - 2 months ago

Prenetics completes $70M Insighta sale to Tencent

Feb 18, 2026, 9:25 AM EST - 2 months ago

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

2026-02-18T14:20:59.000Z - 2 months ago

Prenetics reports Q4 EPS ($1.77) vs. ($1.01) last year

Feb 18, 2026, 9:11 AM EST - 2 months ago

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

Feb 17, 2026, 4:30 PM EST - 3 months ago

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

2026-02-17T13:21:07.000Z - 3 months ago

Prenetics completes $70M Insighta Sale to Tencent

2026-02-13T13:16:34.000Z - 3 months ago

Prenetics announces Formula 1’s Ollie Bearman as newest Global Ambassador

Feb 13, 2026, 8:00 AM EST - 3 months ago

Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

2026-02-11T10:05:31.000Z - 3 months ago

Prenetics initiated with a Buy at Roth Capital

Jan 21, 2026, 8:30 AM EST - 3 months ago

Prenetics Global Transcript: Sidoti Micro-Cap Virtual Investor Conference

2026-01-06T13:26:48.000Z - 4 months ago

Prenetics completes sale of its 3PL distribution business

2026-01-05T13:11:10.000Z - 4 months ago

Prenetics provides update on voluntary warrant exchange program

Dec 30, 2025, 3:06 PM EST - 4 months ago

Buying bitcoin is no longer a thing for this David Beckham-backed health company

MSTR

2025-12-30T13:26:44.000Z - 4 months ago

Prenetics updates capital allocation strategy, ceases bitcoin purchases

2025-12-30T13:26:36.000Z - 4 months ago

Prenetics sees FY26 IM8 revenue $180M-$200M

2025-12-23T14:15:07.000Z - 5 months ago

Prenetics enters warrant exchange agreements

Dec 23, 2025, 9:08 AM EST - 5 months ago

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Dec 10, 2025, 10:00 AM EST - 5 months ago

Prenetics Global Transcript: Sidoti's Year End Virtual Investor Conference

Nov 25, 2025, 8:49 AM EST - 6 months ago

Prenetics Announces Upcoming Conference Participation

Nov 24, 2025, 7:30 AM EST - 6 months ago

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Nov 14, 2025, 8:35 AM EST - 6 months ago

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Nov 10, 2025, 8:30 AM EST - 6 months ago

Prenetics Global Earnings Call Transcript: Q3 2025

Nov 10, 2025, 7:24 AM EST - 6 months ago

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

EXOD

Nov 4, 2025, 8:00 AM EST - 6 months ago

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Oct 31, 2025, 8:31 AM EDT - 6 months ago

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Oct 29, 2025, 4:05 PM EDT - 6 months ago

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Oct 28, 2025, 2:20 PM EDT - 7 months ago

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 27, 2025, 10:12 AM EDT - 7 months ago

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 8, 2025, 8:04 AM EDT - 7 months ago

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Sep 30, 2025, 8:00 AM EDT - 8 months ago

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Sep 12, 2025, 8:30 AM EDT - 8 months ago

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

Jun 26, 2025, 4:30 AM EDT - 11 months ago

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Jun 18, 2025, 8:45 AM EDT - 11 months ago

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Jun 18, 2025, 7:50 AM EDT - 11 months ago

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Mar 5, 2025, 8:30 AM EST - 1 year ago

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Feb 11, 2025, 8:30 AM EST - 1 year ago

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Jan 15, 2025, 8:30 AM EST - 1 year ago

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Dec 5, 2024, 8:30 AM EST - 1 year ago

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Dec 4, 2024, 4:05 PM EST - 1 year ago

Prenetics Announces Participation in December Investor Conferences

Nov 27, 2024, 8:30 AM EST - 1 year ago

Prenetics Announces Third Quarter 2024 Financial Results

Nov 18, 2024, 6:57 AM EST - 1 year ago

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:00 AM EST - 1 year ago

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Jul 1, 2024, 8:30 AM EDT - 2 years ago

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Jun 18, 2024, 8:30 AM EDT - 2 years ago

Prenetics Announces First Quarter 2024 Financial Results

Apr 1, 2024, 7:30 AM EDT - 2 years ago

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 9, 2024, 9:25 AM EST - 2 years ago

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Nov 20, 2023, 6:00 AM EST - 2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

Nov 1, 2023, 6:00 AM EDT - 2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Sep 15, 2023, 6:58 AM EDT - 2 years ago

Prenetics Announces Second Quarter 2023 Financial Results

Jun 26, 2023, 2:18 AM EDT - 3 years ago

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Jun 25, 2023, 8:45 PM EDT - 3 years ago

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Jun 5, 2023, 7:00 AM EDT - 3 years ago

Prenetics Announces First Quarter 2023 Financial Results

Mar 14, 2023, 8:49 AM EDT - 3 years ago

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 2, 2023, 7:00 AM EST - 3 years ago

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Feb 2, 2023, 4:01 PM EST - 3 years ago

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 19, 2023, 5:00 AM EST - 3 years ago

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

focafoca99 May. 4 at 1:50 PM

$PRE outlined its complete Bitcoin treasury divestment, selling about 510 BTC.

0 · Reply

SuperGreenToday May. 1 at 12:25 AM

0 · Reply

ZacksSCR Apr. 17 at 10:30 PM

1 · Reply

ZacksSCR Apr. 8 at 3:27 PM

Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz

0 · Reply

focafoca99 Apr. 2 at 7:57 PM

$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.

0 · Reply

Sidoti Mar. 30 at 12:21 PM

New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap

0 · Reply

Sidoti Mar. 20 at 4:55 PM

0 · Reply

positiveguy Mar. 19 at 5:17 PM

$PRE PLEASE BUY IGNITON FROM GAIA . THEY HAVE NO CLUE.

0 · Reply

DARKP00L Mar. 16 at 2:46 PM

$PRE 10:17 on Mar. 16 2026 Lake Street Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $29 #tradeideas

0 · Reply

STACKD0E Mar. 16 at 1:41 PM

$PRE 🙃✨

0 · Reply

rroycenyc Mar. 10 at 3:40 PM

$PRE

0 · Reply

topstockalerts Mar. 6 at 6:43 PM

Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months, saying the move reflects management’s belief that the current stock price undervalues the business. During Feb. 23–27, executives purchased about $1.3 million in shares on the open market at an average price of around $17.11, including roughly $750,000 bought personally by CEO Danny Yeung. Combined with $1.45 million purchased after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180–$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. The company also completed several strategic divestitures in 2025 and early 2026. $PRE

0 · Reply

topstockalerts Mar. 6 at 4:38 PM

Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months. The health sciences company said the move reflects management’s view that the current share price does not reflect the business’s underlying value. During Feb. 23–27, Prenetics executives bought about $1.3 million in shares on the open market at an average price of roughly $17.11, including about $750,000 purchased personally by CEO Danny Yeung. Combined with $1.45 million in purchases after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180–$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. $PRE

0 · Reply

BillionerOfKing Mar. 2 at 11:33 AM

$PRE Current Stock Price: $16.94 Contracts to trade: $17.5 PRE Mar 20 2026 Call Entry: $0.77 Exit: $1.26 ROI: 64% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser Feb. 20 at 3:40 PM

$PRE RSI: 45.40, MACD: 0.7651 Vol: 1.28, MA20: 19.79, MA50: 17.58 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Sidoti Feb. 20 at 2:09 PM

New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap

0 · Reply

StocktwitsEarnings Feb. 18 at 3:38 PM

$PRE Q4 '25 Earnings Results & Recap Prenetics reaffirms its 2026 IM8 revenue guidance of $180M to $200M, implying $250M to $300M in ARR by year-end, while targeting an adjusted EBITDA loss broadly similar to 2025.

0 · Reply

rroycenyc Feb. 18 at 2:35 PM

$PRE

0 · Reply

Stock_Catcher Feb. 18 at 2:26 PM

$PRE Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

0 · Reply

bread90 Feb. 17 at 1:27 PM

$PRE

0 · Reply

Sidoti Feb. 13 at 11:36 AM

New research on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap

0 · Reply

allegedlyshane2 Jan. 29 at 5:43 PM

$PRE new high

0 · Reply

Market Cap	296.14M
Revenue (ttm)	92.39M
Net Income (ttm)	-37.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.82%
Debt to Equity Ratio	0.00

Volume	101,300
Avg Vol	186,004
Day's Range	N/A - N/A
Shares Out	16.87M
Stochastic %K	100%
Beta	0.15
Analysts	Strong Sell
Price Target	$31.25